Editorial
Volume 1 Issue 1 - 2014
Single and Repeated Dose Effects of Phytochemicals in Rodent Behavioural Models
Vikas Kumar1* and Shyam Sunder Chatterjee2
1Department of Pharmaceutics, Banaras Hindu University, India
2Retired head of pharmacology research laboratories, Dr. Willmar Schwabe GmbH & Co. KG, Germany
*Corresponding Author: Vikas Kumar, Department of Pharmaceutics, Neuropharmacology Research Laboratory, Indian Institute of Technology, Banaras Hindu University, Varanasi-221 005, India.
Received: December 01, 2014; Published: December 04, 2014
Citation: Vikas Kumar and Shyam Sunder Chatterjee. “Single and Repeated Dose Eff ects of Phytochemicals in Rodent Behavioural Models”. EC Pharmaceutical Science 1.1 (2014): 16-18.
The common co-morbid psychiatric conditions like depression, anxiety, sleep disturbances and other mental health problems have always been treated with herbal remedies since ancient times [1,2]. Ayurveda is one of the oldest known holistic health care systems recommending diverse medicinal uses of edible and other plant derived products for prevention and cure of mental illnesses commonly associated with almost all chronic medical conditions [3]. Currently available information on medicinal phyto-chemistry and pharmacology of numerous traditionally known herbal remedies are now widely used also for drug discovery purposes. Although experimental strategies and models often used for such purposes are rarely based on holistic therapeutic principles of Ayurvedic and other traditionally known systems of medicine and health care [4], there are now considerable preclinical as well as clinical evidences justifying traditionally known medicinal uses of diverse types of herbal extracts for prevention and cure of mental health problems [2,5]. It is now well recognized also that numerous phytochemicals commonly consumed with such extracts alter the functions of adaptive cellular stress pathways [6-8], and that numerous traditionally known herbal remedies possess adaptogenic properties [9-11]. However, many questions concerning their bioactive principles and their appropriate combinations and daily oral doses and treatment regimen necessary for obtaining health benefits still remain unanswered [2,12,13].
More recent efforts made in our laboratories and elsewhere to identify bioactive constituents or modes of actions on several currently commercialized psychoactive herbal remedies have not only reconfirmed that many of them possess broad spectrums therapeutically interesting bioactivities against metabolic and/or environmental stress triggered pathologies only after their repeated daily oral doses, and that structurally and functionally diverse phytochemicals commonly consumed with every day meals and drinks could as well be involved in their stress response modulating, or adaptogenic and antidepressant and anxiolytics like, activities in rodent models [14-25]. Although the psychopharmacological activity profiles observed after acute and repeated daily doses of herbal adaptogens are always not identical [26], such is not the cases for stress response modulating effects of several (but not all) stress response regulating food phytochemicals encountered in almost all of them. A common characteristic of all such food phytochemicals identified to date is that they possess anti-microbial or bactericidal activities and they are exhaustively and fairly rapidly metabolized by gut microbiota [27-29]. Since it is now evident that alterations in gut microbial ecology influences brain functions in experimental animals and human, and that stress responses are also regulated by gut microbiota [30-36], it could as well be that alterations in gut microbial ecology caused by stress and food phytochemicals consumed with herbal remedies are involved in their modes of actions.
Although phytochemists have known since long that structurally diverse food phytochemicals are present in almost all terrestrial plants, as yet little concentrated efforts have been made to define their roles in medicinally used herbal extracts. During the course of our efforts to identify stress response modulating constituents of several edible plant extracts used in ayurvedic system of medicine as tonics or rejuvenating therapies, we could identify numerous well known edible phytochemicals commonly consumed with food, or medicinally used as vitamins, or often considered as potential drug leads by modern drug discoverers. Since stress response modulating effects of numerous such extracts their formulations are observed after their repeated daily oral doses, we conceived and pharmacologically validated a mouse bioassay system in which the efficacies of single and repeated daily oral doses of edible phytochemicals could be quantified. Some of the observations revealing diverse spectrums of stress response modulating efficacies of different edible phytochemicals in this bioassay have already been published [19], and manuscripts of some others are in press or under preparation. Stress response modulating oral efficacies of almost all (but not every) edible plant extracts or phytochemical tested to date could be detected after their repeated daily doses only. These observations not only point out the importance of ubiquitously present edible phytochemicals in medicinally interesting psychopharmacological activity profiles of herbal remedies, but also suggest that predictive values of observations made in rodent models after repeated daily oral doses of psychoactive herbal remedies should be much higher than those made after their acute oral doses only.
Bibliography
  1. Kessler RC., et al. “Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication”. Archives of General Psychiatry 62.6 (2005): 617-627.
  2. Sarris J., et al. “Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence”. European Neuropsychopharmacology 21.12 (2011): 841-860.
  3. Nagral KS. Ayurved for Modern Medical Practitioners. New Delhi: Chaukhamba Publishing House, 2008.
  4. Chatterjee SS and V Kumar. “Holistic Psychopharmacology and Promiscuous Plants and Principles of Ayurveda”. American Journal of Plant Sciences 3.7A (2012): 1015-1021.
  5. Kennedy DO. Plants and the human brain. New York: Oxford University Press, 2014.
  6. Lee J., et al. “Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system”. Pharmacological Reviews 66.3 (2014): 815-868.
  7. Calabrese V., et al. “Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity”. Biochimica et Biophysica Acta 1822.5 (2012): 753-783.
  8. Finsterwald C and CM Alberini. “Stress and glucocorticoid receptor-dependent mechanisms in long-term memory: from adaptive responses to psychopathologies”. Neurobiology of Learning and Memory 112 (2014): 17-29.
  9. Panossian AG. “Adaptogens in mental and behavioral disorders”. Psychiatric Clinics of North America 36.1 (2013): 49-64.
  10. Stansbury J., et al. “Supporting adrenal function with adaptogenic herbs”. Journal of Restorative Medicine 1.1 (2012): 76-82.
  11. Pawar VS and H Shivakumar. “A current status of adaptogens: natural remedy to stress”. Asian Pacific Journal of Tropical Disease 2.Suppl 1 (2012): S480-S490.
  12. Sunday Ameh J., et al. “Herbal Drug Development from Traditional Formulations: Refocusing Pharmaceutics and Posology for Accelerated Validation”. British Journal of Pharmaceutical Research 4.12 (2014): 1451-1476.
  13. Parletta N., et al. “Nutritional modulation of cognitive function and mental health”. The Journal of Nutritional Biochemistry 24.5 (2013): 725-743.
  14. Grundmann O., et al. “Effects of St. John's wort extract and single constituents on stress-induced hyperthermia in mice”. Planta Medicaica 72.15 (2006): 1366-1371.
  15. Michalski C., et al. “Antistress and antioxidant activity in mice after repeated treatment with St. John's wort extracts of different hyperforin content”. Planta Medica 73 (2007): 538.
  16. Thakur AK., et al. “Anxiolytic-like activity of leaf extract of traditionally used Indian Mustard (Brassica juncea) in diabetic rats”. Tang 3.1 (2013): e7.
  17. Thakur AK., et al. “Protective effects of Andrographis paniculata extract and pure Andrographolide against chronic stress-triggered pathologies in rats”. Cellular and Molecular Neurobiology 34.8 (2014): 1111-1121.
  18. Thakur AK., et al. “Antidepressant-like effects of Brassica juncea L. leaves in diabetic rodents”. Indian Journal of Experimental Biology 52.6 (2014): 613-622.
  19. Langstieh AJ., et al. “Desensitization of Mild Stress Triggered Responses in Mice by a Brassica juncea Leaf Extract and some Ubiquitous Secondary Plant Metabolites”. Pharmacologia 5.9 (2014): 326-338.
  20. Batool F., et al. “Evaluation of antidepressant-like effects of aqueous extract of sea buckthorn (Hippophae rhamnoides L. Ssp. turkestanica) fruits in experimental models of depression”. Pakistan Journal of Botany 43.3 (2011): 1595-1599.
  21. Nogami A., et al. “Effects of yokukansan on anxiety-like behavior in a rat model of cerebrovascular dementia”. Journal of Natural Medicines 65.2 (2011): 275-281.
  22. Husain GM., et al. “Beneficial effect of Hypericum perforatum on depression and anxiety in a type 2 diabetic rat model”. Acta Poloniae Pharmaceutica 68.6 (6): 913-918.
  23. Singh GK., et al. “Beneficial effects of Fumaria indica on chronic stress-induced neurobehavioral and biochemical perturbations in rats”. Chinese Medicine 3.1 (2012): 49-60.
  24. Kumar V. “Characterization of anxiolytic and neuropharmacological activities of Silexan”. Wiener Medizinische Wochenschrift 163.3-4 (2013): 89-94.
  25. Singh GK., et al. “Potential antianxiety activity of Fumaria indica: A preclinical study”. Pharmacognosy Magazine 9.33 (2013): 14-22.
  26. Panossian A and H Wagner. “Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration”. Phytotherapy Research 19.10 (2005): 819-838.
  27. Cowan MM. “Plant products as antimicrobial agents”. Clinical Microbiology Reviews 12.4 (1999): 564-582.
  28. Lee WJ and K Hase. “Gut microbiota-generated metabolites in animal health and disease”. Nature Chemical Biology 10.6 (2014): 416-424.
  29. Marin Laura., et al. “Bioavailability of Dietary Polyphenols and Gut Microbiota Metabolism: Antimicrobial Properties”. BioMed Research International Article ID: 905215.
  30. Dinan TG and JF Cryan. “Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology”. Psychoneuroendocrinoloy 37.9 (2012): 1369-1378.
  31. Martin FPJ., et al. “Metabolic effects of dark chocolate consumption on energy, gut microbiota, and stress-related metabolism in free-living subjects”. Journal of Proteome Research 8.12 (2009): 5568-5579.
  32. Bendtsen KMB., et al. “Gut microbiota composition is correlated to grid floor induced stress and behavior in the BALB/c mouse”. PloS one 7.10 (2012): e46231.
  33. Crumeyrolle-Arias M., et al. “Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats”. Psychoneuroendocrinology 42 (2014): 207-217.
  34. Mayer EA. “Gut feelings: the emerging biology of gut-brain communication”. Nature Reviews Neuroscience 12.8 (2011): 453-466.
  35. Cryan JF and TG Dinan. “Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour”. Nature Reviews Neuroscience 13.10 (2012): 701-712.
  36. Collins SM., et al. “The interplay between the intestinal microbiota and the brain”. Nature Reviews Neuroscience 10.11 (2012): 735-742.
Copyright: © 2014 Vikas Kumar., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PubMed Indexed Article

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


News and Events

Best Article of the Issue

The Editors of respective journals will elect one Best Article after each issue release and the authors of the selected article will be provided with a certificate of "Best Article of the Issue".

Submission Timeline for April Issue

E-Cronicon delightfully welcomes the authors for submission of novel research towards June issue of respective journals. Submissions are accepted on/before May 09, 2019.

Certification for each Publication

Corresponding Authors will be issued a "Publication Certificate" with all the Co-Authors included as a token of appreciation for publishing their work with respective journals.

Certifying for Review

E-Cronicon certify the Editors for their first review done towards respective journals.

Latest Articles

Recently published articles will be updated immediately after publication in respective journals.